News FDA approves Allergan's migraine tablet ahead of AbbVie merg... Allergan’s migraine tablet Ubrelvy (ubrogepant) has been approved in the US for the acute treatment of patients with or without aura.
News Neurocrine and Xenon agree $1.75bn epilepsy R&D tie-up Two biotechs, Neurocrine Biosciences and Xenon, have announced a licence and collaboration agreement to develop first-in-class treatments for epilepsy in a deal worth up to $1.75 billion.
Views & Analysis Searching for new hope in Alzheimer’s For the best part of two decades, it seemed as if pharma hit a brick wall as it tried to find new treatments for Alzheimer’s.
News Macmillan lends support to UK prostate cancer data project Prostate Progress, a data-powered project to find better tests, treatments, and care for prostate cancer, is expanding via an alliance with Macmillan.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.